21 Nov 2022 Bionest Competitors Collaborate to Understand Shared DMD Adverse Event Adverse responses to experimental gene therapies for Duchenne muscular dystrophy leads to unique collaboration between pharma competitors.
7 Nov 2022 Bionest Down to the Wire: The Race Between Amgen and Mirati for KRAS-Inhibitor Approvals Who is ahead in the race for KRAS-inhibitor approval? We explore the latest drug development updates for sotorasib and adagrasib.